Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
69.6M
-
Shares change
-
+1.53M
-
Total reported value, excl. options
-
$452M
-
Value change
-
+$12.2M
-
Number of buys
-
55
-
Number of sells
-
-40
-
Price
-
$6.50
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q3 2022
119 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q3 2022.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.6M shares
of 107M outstanding shares and own 65.15% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (10.7M shares), BlackRock Inc. (6.45M shares), Vitruvian Partners LLP (5.04M shares), VANGUARD GROUP INC (4.67M shares), Blue Water Life Science Advisors, LP (3.23M shares), Holocene Advisors, LP (3.04M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.54M shares), BAMCO INC /NY/ (2.27M shares), ArrowMark Colorado Holdings LLC (2.23M shares), and RIVER & MERCANTILE ASSET MANAGEMENT LLP (1.87M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.